N-cyclopentyl-3-((4-(2,3-dichlorophenyl) piperazin-1-yl) (2-hydroxyphenyl) methyl) benzamide

inhibitor of human BCL-2-associated death promoter (hBAD) phorsphorylation at Ser99

Also Known As:

N-cyclopentyl-3-((4-(2,3-dichlorophenyl)piperazin-1-yl) (2-hydroxyphenyl)methyl)benzamide

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Basappa,: 1 article (10/2018)
2.	Bender, Andreas: 1 article (10/2018)
3.	Fuchs, Julian E: 1 article (10/2018)
4.	Girish, Kesturu S: 1 article (10/2018)
5.	Lobie, Peter E: 1 article (10/2018)
6.	Ma, Lan: 1 article (10/2018)
7.	Mohan, Chakrabhavi Dhananjaya: 1 article (10/2018)
8.	Pandey, Vijay: 1 article (10/2018)
9.	Rangappa, Kanchugarakoppal S: 1 article (10/2018)
10.	Rangappa, Shobith: 1 article (10/2018)

1.	Carcinoma (Carcinomatosis) 10/30/2018 - "Based on apoptotic efficacy against mammary carcinoma cells, N-cyclopentyl-3-((4-(2,3-dichlorophenyl) piperazin-1-yl) (2-hydroxyphenyl) methyl) benzamide (NPB) was identified as a potential lead compound. "

1.	4-nitrophenethyl bromide (NPB)